How GLP-1 Weight Loss Drugs Are Changing Consumer Shopping Habits
The growing use of glucagon-like peptide-1 receptor agonists for weight management leads to measurable effects. Behavioral data show that…
-
-
GLP-1 Drugs Reshape Consumer Markets as Appetite Suppression Drives Structural Demand Shifts
GLP-1 receptor agonists now impact markets far beyond their original medical uses. About 30 million people take these medications…
-
Hashimoto’s Disease and GLP-1 Medications: What You Need to Know
Hashimoto’s thyroiditis is the most common autoimmune thyroid condition, and it affects millions of people. In this disease, the…
-
Unauthorized GLP-1 Compounding Raises Safety Concerns and Threatens Future Drug Innovation, PRI Brief Finds
Unauthorized Compounding Raises Safety Concerns and Threatens Innovation A new policy brief warns that unauthorized compounded weight loss medications…
-
Structure Therapeutics’ Oral GLP-1 Candidate Aleniglipron Posts 16.2% Weight Loss in Phase 2 Trial
Structure Therapeutics just shared exciting new results from a mid-stage clinical trial for its experimental weight loss pill, aleniglipron….
-
First Dual GLP-1/GIP Receptor Agonist for Type 1 Diabetes Demonstrates Glycemic and Weight Benefits in Phase 2 Trial
Doctors recently tested a new once-daily shot called acmopatide in a phase 2 medical study with adults who have…
-
GLP-1 Drug Coverage Emerges as a Decisive Workplace Benefit, Particularly Among Younger Workers
A growing consideration in career choices is employer-sponsored GLP-1 receptor agonist coverage. This trend is highlighted by a recent…
-
GLP-1 Receptor Agonists Associated With Lower Breast Cancer Incidence
A substantial correlation between the usage of GLP-1 receptor agonists and lower risks of breast cancer detection was found…
-
Global Alignment Could Expand GLP-1 Access
Generic drugs delivered extraordinary savings over the past three decades. Federal agencies approved copies of brand name small molecule…
-
GLP-1 Drugs Expand Beyond Weight Loss, but Evidence Gaps Demand Caution
Semaglutide and tirzepatide drive drugs like Ozempic and Wegovy. They have rapidly moved past their original uses. Researchers now…
